Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$1.87 - $2.78 $774,034 - $1.15 Million
413,922 Added 1515.64%
441,232 $1.2 Million
Q4 2023

Feb 14, 2024

BUY
$1.59 - $2.73 $33,607 - $57,704
21,137 Added 342.41%
27,310 $60,000
Q3 2023

Nov 14, 2023

SELL
$1.9 - $3.05 $18,240 - $29,280
-9,600 Reduced 60.86%
6,173 $17,000
Q2 2023

Aug 14, 2023

BUY
$1.47 - $2.56 $8,505 - $14,812
5,786 Added 57.94%
15,773 $30,000
Q1 2023

May 15, 2023

SELL
$1.3 - $2.24 $188,487 - $324,777
-144,990 Reduced 93.56%
9,987 $19,000
Q4 2022

Feb 14, 2023

BUY
$0.93 - $1.52 $37,398 - $61,123
40,213 Added 35.04%
154,977 $181,000
Q3 2022

Nov 14, 2022

SELL
$1.1 - $2.06 $12,141 - $22,738
-11,038 Reduced 8.77%
114,764 $126,000
Q2 2022

Aug 15, 2022

BUY
$1.6 - $3.99 $201,283 - $501,949
125,802 New
125,802 $201,000
Q1 2022

May 16, 2022

SELL
$2.8 - $3.96 $49,728 - $70,329
-17,760 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$3.63 - $6.13 $64,468 - $108,868
17,760 New
17,760 $70,000
Q3 2021

Nov 15, 2021

SELL
$5.5 - $7.41 $360,200 - $485,288
-65,491 Closed
0 $0
Q2 2021

Aug 16, 2021

SELL
$4.35 - $6.35 $80,335 - $117,271
-18,468 Reduced 22.0%
65,491 $403,000
Q1 2021

May 17, 2021

BUY
$3.94 - $7.09 $215,084 - $387,043
54,590 Added 185.88%
83,959 $379,000
Q4 2020

Feb 16, 2021

BUY
$5.45 - $8.65 $160,061 - $254,041
29,369 New
29,369 $176,000
Q1 2020

May 15, 2020

SELL
$1.24 - $4.35 $21,311 - $74,763
-17,187 Closed
0 $0
Q4 2019

Feb 14, 2020

SELL
$2.3 - $5.12 $175,480 - $390,635
-76,296 Reduced 81.61%
17,187 $60,000
Q3 2019

Nov 14, 2019

BUY
$4.63 - $12.15 $246,658 - $647,279
53,274 Added 132.49%
93,483 $433,000
Q2 2019

Aug 14, 2019

SELL
$11.49 - $14.17 $1.16 Million - $1.43 Million
-100,828 Reduced 71.49%
40,209 $495,000
Q1 2019

May 15, 2019

BUY
$8.47 - $14.36 $974,676 - $1.65 Million
115,074 Added 443.22%
141,037 $1.87 Million
Q4 2018

Feb 14, 2019

BUY
$7.18 - $8.83 $186,414 - $229,253
25,963 New
25,963 $224,000

Others Institutions Holding LAB

About STANDARD BIOTOOLS INC.


  • Ticker LAB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 78,654,800
  • Market Cap $131M
  • Description
  • Standard BioTools Inc. creates, manufactures, and markets instruments, consumables, reagents, and software for researchers and clinical laboratories worldwide. It offers analytical systems, such as Helios, a CyTOF system, as well as Hyperion imaging systems, Hyperion tissue imagers, and flow conductors; and assays and reagents, including Maxpar ...
More about LAB
Track This Portfolio

Track Cubist Systematic Strategies, LLC Portfolio

Follow Cubist Systematic Strategies, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.